首页|乙型肝炎肝纤维化患者的外泌体、血清及肝组织中miR-92a-3p的表达及意义

乙型肝炎肝纤维化患者的外泌体、血清及肝组织中miR-92a-3p的表达及意义

扫码查看
目的 探讨乙型肝炎肝纤维化患者的外泌体、血清及肝组织中miR-92a-3p的表达及意义.方法 实时荧光定量PCR检测乙型肝炎患者肝纤维化不同阶段的外泌体、血清及肝组织中miR-92a-3p的表达水平.比较miR-92a-3p在肝纤维化不同时期表达水平的差异使用Mann-Whitney秩和检验或Kruskal-Wallis检验;采用Spearman相关分析miR-92a-3p表达水平在外泌体、血清及肝组织中的相关性.应用受试者工作特征曲线下面积(AUC)评估外泌体miR-92a-3p和血清miR-92a-3p对乙型肝炎显著性肝纤维化的预测效能.结果 外泌体miR-92a-3p的表达量在肝纤维化不同分期差异显著(P<0.05),S2-4期外泌体miR-92a-3p的表达量显著高于S0-1期(P<0.0001);血清miR-92a-3p在S0-1期、S2期、S3期及S4期的相对表达量分别为0.69±0.20、1.35±1.01、0.88±0.74、0.87±1.33,差异无统计学意义(F=3.06,P=0.381);肝组织 miR-92a-3p 在 S0-1 期、S2 期、S3 期及 S4 期的相对表达量分别为 1.69±1.31、1.54±1.26、1.05±0.61、0.68±0.54,差异无统计学意义(F=6.16,P=0.104).外泌体miR-92a-3p的表达水平与血清miR-92a-3p没有显著的相关性(r=0.1787,P=0.108),外泌体miR-92a-3p的表达水平与肝组织miR-92a-3p也没有显著的相关性(r=0.051,P=0.731).当cut-off值为0.245时,血清miR-92a-3p的AUC为0.61(95%CI:0.48~0.75),对显著性肝纤维化诊断的敏感度和特异度分别为 63.46%和 60%;外泌体 miR-92a-3p 在 cut-off 值为 0.7459 时,AUC 为 0.87(95%CI:0.80~0.94),诊断显著性肝纤维化的敏感度和特异度分别为84.13%和72.09%.结论 miR-92a-3p的表达水平在外泌体、血清及肝组织没有显著相关性.miR-92a-3p在外泌体的浓度显著高于血清和肝组织,与血清miR-92a-3p相比,外泌体miR-92a-3p对乙型肝炎患者显著性肝纤维化的诊断效能更高.
The expression levels and significance of miR-92a-3p in exosomes,serum and liver tissue of patients with hepatitis B-related liver fibrosis
Objective To investigate the expression levels of microRNA miR-92a-3p in exosomes,serum and liver tissue samples of patients with HBV-related hepatic fibrosis and to analyze the difference and significance.Methods Real-time fluorescent quantitative PCR technology was used to detect the expression levels of miR-92a-3p in exosomes,serum,and liver tissue of patients with hepatitis B-related liver fibrosis at different stages.The Mann-Whitney U test or Kruskal-Wallis test was used to compare the differences in miR-92a-3p expression levels during different stages of liver fibrosis.Spearman's correlation coefficient method was employed to analyze the correlation between the level of miR-92a-3p in exosomes and that in serum and liver tissue.The receiver operating characteristic curve(ROC)was applied to evaluate the predictive efficacy of exosomal and serum miR-92a-3p levels for significant liver fibrosis in hepatitis B.Results The expression level of miR-92a-3p in exosomes showed significant differences among different stages of liver fibrosis(P<0.05).The expression level of miR-92a-3p in exosomes from patients in S2-4 stages was significantly higher than that in S0-1 stages(P<0.0001).The relative expression levels of serum miR-92a-3p in S0-1,S2,S3 and S4 stages were 0.69±0.20,1.01±1.35,0.74±0.88 and 0.87±1.33,respectively.There was no statistically significant difference in the expression level of miR-92a-3p in serum among different stages of liver fibrosis(P=0.3817).The relative expression levels of liver tissue miR-92a-3p in S0-1,S2,S3 and S4 stages were 1.69±1.31,1.54±1.26,1.05±0.61 and 0.68±0.54,respectively.Similarly,no statistically significant difference was observed in the expression level of miR-92a-3p in liver tissue among different stages of liver fibrosis(P=0.1040).The expression level of miR-92a-3p in exosomes did not show a significant correlation with its expression level in serum(r=0.1787,P=0.1083).Similarly,there was no significant correlation between the expression levels of miR-92a-3p in exosomes and liver tissue(r=0.051,P=0.7311).When the cut-off value was 0.245,the AUROC for serum miR-92a-3p was 0.61(95%CI:0.48~0.75),with a sensitivity and specificity for diagnosing significant liver fibrosis of 63.46%and 60%,respectively.For exosomal miR-92a-3p,at a cut-off value of 0.7459,the AUROC was highest at 0.87(95%CI:0.80~0.94),with a sensitivity and specificity for diagnosing significant liver fibrosis of 84.13%and 72.09%,respectively.Conclusion The expression levels of miR-92a-3p in exosomes,serum,and liver tissue showed no significant correlation.The concentration of miR-92a-3p in exosomes is significantly higher than in serum and liver tissue,indicating that circulating miR-92a-3p is enriched in exosomes.Compared to serum miR-92a-3p,exosomal miR-92a-3p demonstrated higher diagnostic efficacy for significant liver fibrosis in hepatitis B patients.

miR-92a-3pExosomesSerumLiver tissueLiver fibrosis

王倩倩、蒋旭华、李新艳、宋杰、张毅、季媛媛、任晓静、戚勋、陈良、张键、黄玉仙

展开 >

201104 上海市老年医学中心康复医学科

复旦大学附属中山医院康复医学科

复旦大学附属公共卫生临床中心肝病科

miR-92a-3p 外泌体 血清 肝组织 肝纤维化

2024

肝脏
上海市医学会

肝脏

CSTPCD
影响因子:0.71
ISSN:1008-1704
年,卷(期):2024.29(11)